SS Innovations International (SSII) EBIT Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 38.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.55% |
| Dec 31, 2025 | 56.84% |
| Sep 30, 2025 | 42.73% |
| Jun 30, 2025 | 102.37% |
| Mar 31, 2025 | 39.77% |
| Dec 31, 2024 | -26.30% |
| Sep 30, 2024 | -73.03% |
| Jun 30, 2024 | 21.02% |
| Mar 31, 2024 | -818.37% |
| Dec 31, 2023 | -1,286.52% |
| Sep 30, 2023 | -335.38% |
| Jun 30, 2023 | -615.97% |
| Mar 31, 2023 | -1,231.28% |
| Dec 31, 2022 | -147.93% |
| Sep 30, 2022 | -1.72% |
| Jun 30, 2022 | -75.85% |
| Mar 31, 2022 | 73.20% |
| Dec 31, 2021 | -59.52% |
| Sep 30, 2021 | -11.46% |
| Jun 30, 2021 | -87.43% |
| Mar 31, 2021 | 2.16% |
| Dec 31, 2020 | 78.85% |
| Sep 30, 2020 | 73.02% |
| Jun 30, 2020 | 58.69% |
| Mar 31, 2020 | 22.23% |
| Dec 31, 2019 | -378.44% |
| Sep 30, 2019 | -367.91% |
| Jun 30, 2019 | -159.12% |
| Mar 31, 2019 | -65.40% |
| Dec 31, 2018 | 53.77% |
| Sep 30, 2018 | -73.78% |
| Jun 30, 2018 | -15.21% |
| Mar 31, 2018 | -27.27% |
| Dec 31, 2017 | -155.04% |
| Sep 30, 2017 | 27.79% |
| Jun 30, 2017 | -349.30% |